Annual report pursuant to Section 13 and 15(d)

Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details)

v3.20.4
Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)
Dec. 31, 2020
Dec. 31, 2019
Accrued Liabilities and Other Liabilities [Abstract]    
Research and development expenses $ 4,939,095 $ 920,901
Compensation and benefits 3,119,399 1,591,964
General and administrative 771,381 360,016
Sales and marketing 30,795 120,056
Sales returns and allowances 1,793,811 2,284,175
Medicaid rebates 118,655 118,271
Lease liability, current 426,346 155,815
Other 110,239 89,054
Accrued expenses and other current liabilities $ 11,309,721 $ 5,640,252